SAB Biotherapeutics, Inc. (SAB) is a clinical-stage, biopharmaceutical company advancing a new class of immunotherapies leveraging fully human polyclonal antibodies. Utilizing some of the most complex genetic engineering and antibody science in the world, SAB has developed the only platform that can rapidly produce natural, specifically-targeted, high-potency, human polyclonal immunotherapies at commercial scale. SAB-185, a fully-human polyclonal antibody therapeutic candidate for COVID-19, is being developed with initial funding supported by the Biomedical Advanced Research Development Authority (BARDA), part of the Assistant Secretary for Preparedness and Response (ASPR) at the U.S. Department of Health and Human Services and the Department of Defense (DoD) Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND) Joint Project Lead for Enabling Biotechnologies (JPL-EB). In addition to COVID-19, the company's pipeline also includes programs in Type 1 diabetes, organ transplant, influenza and an human immune globulin (IgG) for mediated diseases.
View Top Employees from SAB Biotherapeutics , Inc.Website | http://www.sabbiotherapeutics.com |
Revenue | $14 million |
Funding | $77.2 million |
Employees | 8 (8 on RocketReach) |
Founded | 2014 |
Address | 2301 E 60th St N, Sioux Falls, South Dakota 57104, US |
Phone | (605) 679-6980 |
Technologies |
JavaScript,
HTML,
Twitter
+29 more
(view full list)
|
Industry | Biotechnology, Drug Discovery, Pharmaceuticals, Science and Engineering, Therapeutic Devices, Healthcare, Clinical Trials, Health Care, Therapeutics |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 541 Companies, NAICS Code 5417 Companies, NAICS Code 54 Companies |
Looking for a particular SAB Biotherapeutics , Inc. employee's phone or email?
The SAB Biotherapeutics , Inc. annual revenue was $14 million in 2023.
Jerry Pommer is the Vice President of Regulatory Compliance of SAB Biotherapeutics , Inc..
8 people are employed at SAB Biotherapeutics , Inc..
SAB Biotherapeutics , Inc. is based in Sioux Falls, South Dakota.
The NAICS codes for SAB Biotherapeutics , Inc. are [541, 5417, 54].
The SIC codes for SAB Biotherapeutics , Inc. are [87, 873].